World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
71
Citations
17579
World Ranking
2415
National Ranking
81

Klaus L. Leenders publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Klaus L. Leenders sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 216 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Klaus L. Leenders D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Klaus L. Leenders sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 71 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Pathology
  • Neuroscience

His primary scientific interests are in Internal medicine, Putamen, Caudate nucleus, Dopamine and Pathology. His study in Internal medicine focuses on Dopamine receptor D2 and Raclopride. His biological study spans a wide range of topics, including Dopaminergic, Parkinson's disease and Striatum.

His Dopamine study results in a more complete grasp of Endocrinology. His Endocrinology study integrates concerns from other disciplines, such as Frontal lobe and Apparent oxygen utilisation. His studies deal with areas such as Positron emission tomography, Multiple sclerosis, Blood flow and Blood volume as well as Pathology.

His most cited work include:

  • Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]raclopride (179 citations)
  • Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]raclopride (179 citations)
  • Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]raclopride (179 citations)

What are the main themes of his work throughout his whole career to date?

K. L. Leenders focuses on Internal medicine, Positron emission tomography, Pathology, Endocrinology and Putamen. His Internal medicine and Central nervous system disease, Dopamine receptor D2, Raclopride, Parkinson's disease and Central nervous system investigations all form part of his Internal medicine research activities. His studies in Positron emission tomography integrate themes in fields like Ictal, Blood flow, Blood–brain barrier and Meningioma.

His Degenerative disease and Brain tumor study in the realm of Pathology interacts with subjects such as Distribution Volume. His study in Putamen is interdisciplinary in nature, drawing from both Levodopa, Caudate nucleus and Substantia nigra, Dopaminergic. His Caudate nucleus research includes themes of Basal ganglia and Striatum, Dopamine.

He most often published in these fields:

  • Internal medicine (51.19%)
  • Positron emission tomography (38.10%)
  • Pathology (27.38%)

What were the highlights of his more recent work (between 1998-2009)?

  • Central nervous system disease (22.62%)
  • Positron emission tomography (38.10%)
  • Nuclear medicine (20.24%)

In recent papers he was focusing on the following fields of study:

K. L. Leenders spends much of his time researching Central nervous system disease, Positron emission tomography, Nuclear medicine, Neuroscience and Putamen. His study with Central nervous system disease involves better knowledge in Internal medicine. The Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology.

The study incorporates disciplines such as Pharmacokinetics, Washout, Blood plasma and Meningioma in addition to Positron emission tomography. His work in Putamen is not limited to one particular discipline; it also encompasses Levodopa. His work deals with themes such as Associative learning, Verbal fluency test, Trail Making Test and Raclopride, which intersect with Caudate nucleus.

Between 1998 and 2009, his most popular works were:

  • Metabolic Network Abnormalities in Early Huntington’s Disease: An [18F]FDG PET Study (146 citations)
  • Reproducibility of regional metabolic covariance patterns: comparison of four populations. (107 citations)
  • Imaging Brain Tumor Proliferative Activity with [124I]Iododeoxyuridine (93 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Neuroscience
  • Pathology

Nuclear medicine, Neuroscience, Positron emission tomography, Huntington's disease and Central nervous system disease are his primary areas of study. His Nuclear medicine research is multidisciplinary, relying on both Pharmacokinetics, Washout, Blood plasma and Meningioma. His research in Striatum, Medial frontal gyrus, Midbrain and Limbic lobe are components of Neuroscience.

His Positron emission tomography research incorporates elements of Internal medicine, Disease, Pathology and Metabolic network. His studies in Huntington's disease integrate themes in fields like Caudate nucleus, Basal ganglia, Verbal fluency test and Raclopride. His Central nervous system disease research is multidisciplinary, incorporating elements of Fluorodeoxyglucose, Brain network and Cohort.

Best Publications

  • Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age.

    K. L. Leenders;D. Perani;A. A. Lammertsma;J. D. Heather

  • Blood-brain barrier dysfunction in parkinsonian midbrain in vivo.

    Rudie Kortekaas;Klaus L. Leenders;Joost C. H. van Oostrom;Willem Vaalburg

  • EVALUATION OF CEREBRAL PERFUSION RESERVE IN PATIENTS WITH CAROTID-ARTERY OCCLUSION

    J.M Gibbs;K.L Leenders;R.J.S Wise;T Jones

  • The Nigrostriatal Dopaminergic System Assessed in Vivo by Positron Emission Tomography in Healthy Volunteer Subjects and Patients With Parkinson's Disease

    K. L. Leenders;E. P. Salmon;P. Tyrrell;D. Perani

  • Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

    F.X. Vollenweider;K.L. Leenders;I. Øye;D. Hell

  • Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

    F.X Vollenweider;K.L Leenders;C Scharfetter;A Antonini

  • Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease

    A. Antonini;K. L. Leenders;R. Spiegel;D. Meier

  • THE RELATIONSHIP BETWEEN LOCOMOTOR DISABILITY, AUTONOMIC DYSFUNCTION, AND THE INTEGRITY OF THE STRIATAL DOPAMINERGIC SYSTEM IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY, PURE AUTONOMIC FAILURE, AND PARKINSON'S DISEASE, STUDIED WITH PET

    D. J. Brooks;E. P. Salmon;C. J. Mathias;N. Quinn

  • Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease

    A Antonini;K L Leenders;P Vontobel;R P Maguire

  • How does the human brain deal with a spinal cord injury

    M. Bruehlmeier;V. Dietz;K. L. Leenders;U. Roelcke

  • Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.

    Angelo Antonini;Johannes Schwarz;Wolfgang H. Oertel;Oliver Pogarell

  • Transplantation of fetal dopamine neurons in Parkinson's disease: PET {18F}6‐L‐fluorodopa studies in two patients with putaminal implants

    Sawle Gv;Bloomfield Pm;Björklund A;Brooks Dj

  • Parkinson's disease: the syndrome, the pathogenesis and pathophysiology.

    Anna L. Bartels;Klaus L. Leenders

  • [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease Influence of L‐dopa and lisuride therapy on striatal dopamine D2‐receptors

    A. Antonini;J. Schwarz;W. H. Oertel;H. F. Beer

  • T2 relaxation time in patients with Parkinson's disease

    A. Antonini;K. L. Leenders;D. Meier;W. H. Oertel

  • Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.

    Angelo Antonini;Peter Vontobel;Maria Psylla;Ilonka Günther

  • Metabolic Network Abnormalities in Early Huntington’s Disease: An [18F]FDG PET Study

    Andrew Feigin;Klaus L. Leenders;James R. Moeller;John Missimer

  • Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

    Leslie I. Wolfson;Klaus L. Leenders;Lucy L. Brown;Terry Jones

  • Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration

    Anna L. Bartels;Rudie Kortekaas;Joost Bart;Antoon T.M. Willemsen

  • Mesiobasal versus lateral temporal lobe epilepsy : metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography

    Marketa Hajek;Angelo Antonini;Klaus Leonhard Leenders;Heinz Gregor Wieser

  • Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis.

    D J Brooks;K L Leenders;G Head;J Marshall

  • Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography.

    K. L. Leenders;R. S. J. Frackowiak;N. Quinn;C. D. Marsden

  • Pure amnesia after unilateral left polar thalamic infarct: topographic and sequential neuropsychological and metabolic (PET) correlations.

    S Clarke;G Assal;J Bogousslavsky;F Regli

  • Familial parkinsonism with synuclein pathology Clinical and PET studies of A30P mutation carriers

    Rejko Krüger;W. Kuhn;K. L. Leenders;R. Sprengelmeyer

  • Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain: 2. Results in normal subjects and brain tumour and stroke patients.

    Adriaan A. Lammertsma;Richard J. S. Wise;Jon D. Heather;Jeremy M. Gibbs

  • In vivo evaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomography

    S.-M. Aquilonius;K. Bertröm;S-Å. Eckernäs;P. Hartvig

  • [11C]Raclopride‐PET studies of the Huntington's disease rate of progression: Relevance of the trinucleotide repeat length

    Angelo Antonini;Klaus L. Leenders;Klaus L. Leenders;David Eidelberg

  • Intermanual transfer of proximal and distal motor engrams in humans

    Gregor Thut;Gregor Thut;Norman D. Cook;Marianne Regard;Klaus L. Leenders;Klaus L. Leenders

  • Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A F-18-fluorodeoxyglucose positron emission tomography study

    U Roelcke;L Kappos;J LechnerScott;H Brunnschweiler

Frequent Co-Authors

Angelo Antonini
Angelo Antonini University of Padua
David J. Brooks
David J. Brooks Newcastle University
Terry Jones
Terry Jones University of California, Davis
Gregor Thut
Gregor Thut Centre national de la recherche scientifique, CNRS
Marianne Regard
Marianne Regard University of Zurich
Heinz Gregor Wieser
Heinz Gregor Wieser University of Zurich
Anders Björklund
Anders Björklund Lund University
Håkan Widner
Håkan Widner Lund University
Johannes Schwarz
Johannes Schwarz Leipzig University
Charles David Marsden
Charles David Marsden King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Klaus L. Leenders

Trending Scientists

Recently Published Articles